Haleon PLC (GB:HLN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Haleon PLC has announced the publication of a supplemental update to its £10 billion Euro Medium Term Note Programme, reflecting the latest information for investors and guaranteeing the notes through the company. The update, which is crucial for stakeholders, is now available on Haleon’s website for review. Haleon, listed on both the LSE and NYSE, is known for its leading consumer health products, including well-known brands like Advil, Sensodyne, and Centrum.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.